Investor Stock List
Ranked #4,066 of 8,699 institutional investors

Sio Capital Management, LLC

New York, NY

$424M
US stock portfolio at live prices · today +$1.1M (+0.27%)
Live prices, last trade 10:02 AM ET
Value at quarter end (Q3 2026)
$470M
Change from Q2 2026
−$113.8M (−19.50%)
Positions
47 · 10 new, 13 sold out
Filed
Nov 16, 2026

Not counted in the ranking: put options on $58.8M. $46.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
GMED 7.78%GSK 7.67%AVR 6.17%SENS 4.77%MRK 4.68%
StockSharesValue, live% of portfoliovs Q2 2026
GMED Globus Medical, Inc.476,109$33.0M7.78%Added +58%
GSK GSK plc671,121$32.5M7.67%Added +54%
AVR Anteris Technologies Global Corp.5,179,464$26.2M6.17%Reduced −7%
SENS Senseonics Holdings, Inc.2,290,860$20.2M4.77%Added +44%
MRK Merck & Co., Inc.145,485$19.8M4.68%New
REPL Replimune Group, Inc.865,331$16.9M3.98%New
MMS Maximus, Inc.268,280$16.7M3.95%Reduced −62%
SNY Sanofi356,182$16.6M3.93%Reduced −2%
LQDA Liquidia Corporation282,000$16.1M3.81%New
VTRS Viatris Inc.755,490$15.1M3.55%Reduced −21%
IDYA IDEAYA Biosciences, Inc.500,117$13.2M3.12%Added +4%
RLMD Relmada Therapeutics, Inc.3,629,844$11.1M2.63%Added +262%
AVAH Aveanna Healthcare Holdings Inc.1,012,102$10.9M2.58%Added +174%
BMRN BioMarin Pharmaceutical Inc.174,311$10.7M2.52%New
ANIP ANI Pharmaceuticals, Inc.146,268$10.2M2.42%Added +50%
TNGX Tango Therapeutics, Inc.428,860$9.8M2.31%Added +106%
COO The Cooper Companies, Inc.158,053$9.6M2.26%New
CI The Cigna Group33,935$9.4M2.22%Reduced −41%
VIR Vir Biotechnology, Inc.873,375$7.7M1.81%Reduced −19%
CELC Celcuity Inc.126,339$7.2M1.70%Added +15%
RAPP Rapport Therapeutics, Inc.291,231$6.8M1.61%Reduced −5%
ALLO Allogene Therapeutics, Inc.9,104,151$6.0M1.43%Reduced −32%
PTCT PTC Therapeutics, Inc.82,900$4.9M1.15%New
TARA Protara Therapeutics, Inc.1,991,339$4.8M1.13%Added +4%
AQST Aquestive Therapeutics, Inc.1,278,056$4.6M1.09%Reduced −14%
PMVP PMV Pharmaceuticals, Inc.3,634,137$4.5M1.07%Added +38%
QTTB Q32 Bio Inc.529,155$4.4M1.05%New
OKUR OnKure Therapeutics, Inc.1,082,965$3.0M0.71%Added +0%
ANTX AN2 Therapeutics, Inc.548,103$3.0M0.70%Added +3%
SVRA Savara Inc.657,104$2.9M0.69%Added +6%
ZBIO Zenas BioPharma, Inc.95,457$2.4M0.57%Reduced −54%
OVID Ovid Therapeutics Inc.1,005,334$2.3M0.55%Unchanged
SER Serina Therapeutics, Inc.2,000,000$2.3M0.55%Added +100%
IMNM Immunome, Inc.132,097$2.2M0.52%Added +6%
CRBP Corbus Pharmaceuticals Holdings, Inc.766,364$1.9M0.44%New
FULC Fulcrum Therapeutics, Inc.481,601$1.8M0.42%New
DRUG Bright Minds Biosciences Inc.75,152$1.6M0.37%Added +2%
ALHC Alignment Healthcare, Inc.184,424$1.2M0.29%New
XLO Xilio Therapeutics, Inc.152,464$1.2M0.27%Unchanged
QTI QT Imaging Holdings, Inc.440,446$832K0.20%Added +2,791%
IBIO iBio, Inc.904,268$723K0.17%Unchanged
TELA TELA Bio, Inc.636,300$512K0.12%Unchanged
ENVB Enveric Biosciences, Inc.330,000$492K0.12%Added +83%
ALGS Aligos Therapeutics, Inc.327,237$434K0.10%Unchanged
EYPT EyePoint, Inc.373,666$98K<0.1%Reduced −40%
NMTC NeuroOne Medical Technologies Corporation82,767$58K<0.1%Unchanged
MODD Modular Medical, Inc.26,190$46K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
COR Cencora, Inc.173,588$59.7M
WAY Waystar Holding Corp.925,834$25.2M
ORKA Oruka Therapeutics, Inc.177,118$16.9M
REGN Regeneron Pharmaceuticals, Inc.18,000$16.9M
TYRA Tyra Biosciences, Inc.695,315$13.9M
ZBH Zimmer Biomet Holdings, Inc.131,445$13.5M
ABT Abbott Laboratories128,656$13.5M
BMY Bristol-Myers Squibb Company193,500$11.5M
DNTH Dianthus Therapeutics, Inc.59,254$5.1M
OCUL Ocular Therapeutix, Inc.539,493$3.2M
AORT Artivion, Inc.48,481$904K
SION Sionna Therapeutics, Inc.127,808$387K
BBOT BridgeBio Oncology Therapeutics, Inc.130,628$251K